Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,447 total articles
National Healthcare Properties, Inc., a REIT specializing in healthcare real estate focusing on senior housing, has declared quarterly dividends on its 7.375% Series A and 7.125% Series B Cumulative Redeemable Perpetual Preferred Stocks payable in July 2026. The announcement reflects the company’s ongoing commitment to providing regular income to p…
20/20 BioLabs, a Nasdaq-listed company specializing in AI-driven blood tests for early cancer and chronic disease detection, announced a new monthly investor webinar series starting July 1, 2026. The series aims to provide shareholders and potential investors with regular updates on company progress, strategy, and new developments, enhancing transp…
Orchid Island Capital, Inc. has increased its stock repurchase program authorization by an additional 25 million shares, bringing the total repurchase authorization to over 26.6 million shares, or approximately 13.3% of outstanding shares. The company also announced an estimated book value per share increase of 2.3% to 2.8% since March 31, 2026, in…
MacroGenics, a clinical-stage biopharmaceutical company, announced that it will receive a $24.5 million regulatory milestone payment from Sanofi following the FDA's accelerated approval to expand the indication of TZIELD to delay insulin decline in children aged 8 to 17 with stage 3 type 1 diabetes. The approval extends TZIELD’s potential as a dise…
Sun Communities, Inc., a REIT specializing in manufactured housing and RV communities, announced the appointment of Ileana McAlary as General Counsel, Executive Vice President, and Secretary effective June 29, 2026. McAlary brings extensive legal, compliance, and governance experience from previous leadership roles at SpartanNash, Wolverine Worldwi…
Flyte, a regional air mobility subsidiary of Catheter Precision, announced a strategic partnership with sports agency GSE Worldwide and PGA Tour professional Emiliano Grillo at the 2026 U.S. Open. The collaboration aims to address professional athletes' need for efficient regional travel, utilizing Flyte's fleet of Cirrus Vision Jets to offer faste…
Ridgepost Capital (NYSE: RPC) publicly announced the completion of its strategic acquisition of Stellus Capital Management, a well-established direct lender specializing in lower-middle market senior-secured loans. Stellus, with around $4 billion in assets under management, will continue operating under its current management team while benefiting …
Texas Ventures Acquisition IV Corp successfully closed its initial public offering, raising $172.5 million. The special purpose acquisition company (SPAC) will focus on acquiring businesses in industrial technology sectors such as software, IoT, energy transition, logistics, cloud, and 5G communications with goals of cost reductions, environmental …
IMUNON, Inc., a clinical-stage biotechnology company, announced that its CEO Stacy Lindborg, Ph.D., will present at the Life Sciences Investor Forum on June 25, 2026. The company is developing innovative DNA-mediated immunotherapies with its lead candidate IMNN-001 in Phase 3 trials for advanced ovarian cancer, as well as a COVID-19 booster vaccine…
Del Taco, the second-largest Mexican quick service restaurant in the US, has reintroduced its popular slow-cooked Pork Carnitas with an expanded menu featuring five new items including breakfast options. To celebrate America's 250th birthday, Del Taco also brings back its Independence Poppers beverages and fan-favorite Funnel Cake Fries for the sum…
Dyne Therapeutics has appointed Barry Greene, an experienced biopharmaceutical industry leader, to its Board of Directors as the company approaches a transition to a commercial-stage biotech enterprise. Greene's expertise in rare diseases and successful track records in development and commercialization are expected to guide Dyne through potential …
Centessa Pharmaceuticals plc announced that the High Court of Justice of England and Wales has approved Eli Lilly's acquisition of the company. The deal values Centessa at approximately $7.8 billion, with Lilly acquiring Centessa for $38.00 per share plus contingent value rights. The acquisition is expected to close on June 24, 2026, with Centessa'…
CervoMed Inc., a NASDAQ-listed clinical-stage biotechnology company developing treatments for age-related brain disorders, has closed a registered direct offering of 2.5 million shares at $4.00 per share, raising gross proceeds of $10 million. The company plans to use these funds for working capital and general corporate purposes as it advances its…
Safe Bulkers, a marine drybulk transportation service provider listed on the NYSE and Euronext Athens, announced its annual meeting of stockholders to take place on September 10, 2026, in Monaco. Stockholders of record as of July 15, 2026, are eligible to vote. Formal notice and proxy statements will be sent in due course. The company also issued f…
National Healthcare Properties, Inc. announced the final results of its self-tender offers to repurchase up to $100 million aggregate of its Series A and Series B cumulative redeemable perpetual preferred stock. The company accepted about $25.3 million worth of shares representing approximately 14.5% and 16.6% of the outstanding Series A and B shar…
Tango Therapeutics, a clinical-stage biotechnology company specializing in precision cancer medicines, announced the appointment of Robert Azelby to its Board of Directors. Azelby's extensive experience in oncology commercialization and biopharmaceutical leadership is expected to support Tango as it advances vopimetostat, a promising PRMT5 inhibito…
Vivani Medical, a clinical-stage biopharmaceutical company specializing in miniature, ultra long-acting drug implants, announced that CEO Adam Mendelsohn will present a company overview at the 2026 BIO International Convention. Vivani is developing NanoPortal™ implant technology targeting metabolic diseases including obesity and type 2 diabetes, ai…
MoonLake Immunotherapeutics, a clinical-stage biotech company focusing on inflammatory skin and joint diseases, announced a proposed $150 million public offering of Class A ordinary shares and pre-funded warrants. The proceeds will fund research, development, and potential commercialization of their investigational therapy sonelokimab, targeting in…
TTM Technologies (NASDAQ: TTMI) has opened a new Ultra-High-Density Interconnect (Ultra-HDI) printed circuit board manufacturing facility in Syracuse, NY. The $130 million investment, including $30 million from the U.S. Department of War, creates 400 new jobs and strengthens domestic production critical to next-generation defense systems like radar…
Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company specializing in nitric oxide therapies, announced it will report its fiscal fourth quarter and full year 2026 financial results on June 26, 2026, followed by a conference call and webcast with management.
uniQure N.V., a Nasdaq-listed gene therapy company, has initiated a $150 million underwritten public offering of ordinary shares and pre-funded warrants, with an option to sell an additional $22.5 million of shares. The offering is subject to market conditions and aims to support the company’s pipeline of gene therapies targeting severe diseases su…
MKS Inc. has officially opened its new Supercenter Factory in Penang, Malaysia, a strategic move to support the growing global demand for wafer fabrication equipment. The facility, developed in multiple phases with the first phase completed, spans 350,000 square feet and is expected to create over 1,000 jobs. This investment of more than RM400 mill…
Toll Brothers, a leading luxury home builder, revealed plans to launch Hidden Vista, a gated luxury home community in Palm Desert, California. The community will feature sophisticated single-story homes with modern designs, private pools, and a range of customization options. Sales are expected to start in fall 2026, offering residents upscale dese…
Amaze Holdings announces a partnership with third. to host an exclusive VIP dinner for creators and brand executives ahead of VidCon 2026, aiming to foster collaboration and showcase Amaze's latest commerce innovations. The event emphasizes the companies' commitment to advancing creator monetization and commerce through strategic partnerships.
Insight Molecular Diagnostics Inc. (Nasdaq: IMDX) and the American Society of Transplant Surgeons have awarded a $100,000 grant to researchers to study the health economics of in-house versus send-out donor-derived cell-free DNA testing in kidney transplantation. This research aims to provide data on costs, clinical impact, and operational implicat…
